vs
Side-by-side financial comparison of JBT Marel Corp (JBTM) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× JBT Marel Corp). JBT Marel Corp runs the higher net margin — 5.3% vs 4.4%, a 0.8% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $83.5M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 41.2%).
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
JBTM vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $53.1M | $66.5M |
| Gross Margin | 34.5% | 90.5% |
| Operating Margin | 7.2% | 12.4% |
| Net Margin | 5.3% | 4.4% |
| Revenue YoY | 115.6% | 32.8% |
| Net Profit YoY | 858.6% | 143.8% |
| EPS (diluted) | $1.04 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $934.8M | $1.3B | ||
| Q1 25 | $854.1M | $1.1B | ||
| Q4 24 | $467.6M | $1.1B | ||
| Q3 24 | $453.8M | $1.0B | ||
| Q2 24 | $402.3M | $929.2M | ||
| Q1 24 | $392.3M | $751.7M |
| Q4 25 | $53.1M | $66.5M | ||
| Q3 25 | $66.0M | $124.8M | ||
| Q2 25 | $3.4M | $94.3M | ||
| Q1 25 | $-173.0M | $1.3M | ||
| Q4 24 | $-7.0M | $-151.9M | ||
| Q3 24 | $38.9M | $-121.3M | ||
| Q2 24 | $30.7M | $-120.4M | ||
| Q1 24 | $22.8M | $-251.2M |
| Q4 25 | 34.5% | 90.5% | ||
| Q3 25 | 35.9% | 86.1% | ||
| Q2 25 | 35.8% | 87.5% | ||
| Q1 25 | 34.2% | 85.2% | ||
| Q4 24 | 38.4% | 85.8% | ||
| Q3 24 | 36.1% | 83.0% | ||
| Q2 24 | 35.6% | 85.1% | ||
| Q1 24 | 35.8% | 83.4% |
| Q4 25 | 7.2% | 12.4% | ||
| Q3 25 | 10.2% | 11.5% | ||
| Q2 25 | 5.2% | 6.7% | ||
| Q1 25 | -3.9% | 1.0% | ||
| Q4 24 | 3.4% | -7.0% | ||
| Q3 24 | 10.3% | -12.0% | ||
| Q2 24 | 6.7% | -11.5% | ||
| Q1 24 | 7.4% | -34.8% |
| Q4 25 | 5.3% | 4.4% | ||
| Q3 25 | 6.6% | 8.8% | ||
| Q2 25 | 0.4% | 7.2% | ||
| Q1 25 | -20.3% | 0.1% | ||
| Q4 24 | -1.5% | -13.5% | ||
| Q3 24 | 8.6% | -12.1% | ||
| Q2 24 | 7.6% | -13.0% | ||
| Q1 24 | 5.8% | -33.4% |
| Q4 25 | $1.04 | $0.05 | ||
| Q3 25 | $1.26 | $0.08 | ||
| Q2 25 | $0.07 | $0.06 | ||
| Q1 25 | $-3.35 | $0.00 | ||
| Q4 24 | $-0.22 | $-0.10 | ||
| Q3 24 | $1.21 | $-0.09 | ||
| Q2 24 | $0.95 | $-0.09 | ||
| Q1 24 | $0.71 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $4.5B |
| Total DebtLower is stronger | $1.5B | $836.4M |
| Stockholders' EquityBook value | $4.5B | $4.4B |
| Total Assets | $8.2B | $8.2B |
| Debt / EquityLower = less leverage | 0.33× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | $1.2B | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | $1.5B | $836.4M | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $648.3M | — | ||
| Q2 24 | $647.7M | — | ||
| Q1 24 | $647.0M | — |
| Q4 25 | $4.5B | $4.4B | ||
| Q3 25 | $4.4B | $4.1B | ||
| Q2 25 | $4.4B | $3.8B | ||
| Q1 25 | $4.1B | $3.5B | ||
| Q4 24 | $1.5B | $3.3B | ||
| Q3 24 | $1.6B | $3.4B | ||
| Q2 24 | $1.5B | $3.4B | ||
| Q1 24 | $1.5B | $3.4B |
| Q4 25 | $8.2B | $8.2B | ||
| Q3 25 | $8.2B | $7.6B | ||
| Q2 25 | $8.3B | $6.3B | ||
| Q1 25 | $8.0B | $5.8B | ||
| Q4 24 | $3.4B | $5.9B | ||
| Q3 24 | $2.8B | $5.8B | ||
| Q2 24 | $2.7B | $5.7B | ||
| Q1 24 | $2.7B | $5.7B |
| Q4 25 | 0.33× | 0.19× | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.41× | — | ||
| Q2 24 | 0.43× | — | ||
| Q1 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $117.4M | $417.3M |
| Free Cash FlowOCF − Capex | $83.5M | $379.8M |
| FCF MarginFCF / Revenue | 8.3% | 25.4% |
| Capex IntensityCapex / Revenue | 3.4% | 2.5% |
| Cash ConversionOCF / Net Profit | 2.21× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $238.1M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $117.4M | $417.3M | ||
| Q3 25 | $87.7M | $402.6M | ||
| Q2 25 | $102.2M | $263.6M | ||
| Q1 25 | $34.4M | $44.1M | ||
| Q4 24 | $128.7M | $75.2M | ||
| Q3 24 | $71.9M | $188.4M | ||
| Q2 24 | $21.6M | $-95.6M | ||
| Q1 24 | $10.4M | $-308.6M |
| Q4 25 | $83.5M | $379.8M | ||
| Q3 25 | $56.5M | $354.5M | ||
| Q2 25 | $83.7M | $219.8M | ||
| Q1 25 | $14.4M | $-12.3M | ||
| Q4 24 | $118.7M | $-17.3M | ||
| Q3 24 | $65.0M | $54.7M | ||
| Q2 24 | $11.1M | $-205.5M | ||
| Q1 24 | $-100.0K | $-465.1M |
| Q4 25 | 8.3% | 25.4% | ||
| Q3 25 | 5.6% | 25.1% | ||
| Q2 25 | 9.0% | 16.7% | ||
| Q1 25 | 1.7% | -1.1% | ||
| Q4 24 | 25.4% | -1.5% | ||
| Q3 24 | 14.3% | 5.5% | ||
| Q2 24 | 2.8% | -22.1% | ||
| Q1 24 | -0.0% | -61.9% |
| Q4 25 | 3.4% | 2.5% | ||
| Q3 25 | 3.1% | 3.4% | ||
| Q2 25 | 2.0% | 3.3% | ||
| Q1 25 | 2.3% | 5.0% | ||
| Q4 24 | 2.1% | 8.2% | ||
| Q3 24 | 1.5% | 13.3% | ||
| Q2 24 | 2.6% | 11.8% | ||
| Q1 24 | 2.7% | 20.8% |
| Q4 25 | 2.21× | 6.28× | ||
| Q3 25 | 1.33× | 3.22× | ||
| Q2 25 | 30.06× | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
